ClinicalTrials.gov
ClinicalTrials.gov Menu

Multinational Study of Acinetobacter Bloodstream Infection: Clinical Outcomes and Global Epidemiology-PITT Protocol

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00524290
Recruitment Status : Completed
First Posted : September 3, 2007
Last Update Posted : June 14, 2018
Sponsor:
Information provided by (Responsible Party):
Yohei Doi, University of Pittsburgh

Brief Summary:
The objectives of this multinational study are to assess the clinical outcomes of patients with Acinetobacter bloodstream infection and to further assess the predictors of mortality in this patient population. We also aim to characterize the molecular epidemiology of this remarkable organism in an attempt to further understand its transmission dynamics on a global level and to determine whether increased pathogenicity is geographically dependent.

Condition or disease
Acinetobacter Infections

Detailed Description:
Medical records will be reviewed and information collected to assess the clinical outcomes of patients with Acinetobacter bloodstream infection and to further assess the predictors of mortality in this patient population.

Study Type : Observational
Actual Enrollment : 100 participants
Observational Model: Cohort
Time Perspective: Retrospective
Official Title: Multinational Study of Acinetobacter Bloodstream Infection: Clinical Outcomes and Global Epidemiology-PITT Protocol
Actual Study Start Date : April 2009
Actual Primary Completion Date : December 2017
Actual Study Completion Date : December 2017




Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
acinetobacter infections
Criteria

Inclusion Criteria:

  • Patients with Acinetobacter infections

Exclusion Criteria:

  • Those that do not meet entry criteria

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00524290


Locations
United States, Pennsylvania
University of Pittsburgh Medical Center
Pittsburgh, Pennsylvania, United States, 15213
Sponsors and Collaborators
University of Pittsburgh
Investigators
Principal Investigator: David Paterson, MD University of Pittsburgh

Responsible Party: Yohei Doi, Associate Professor, University of Pittsburgh
ClinicalTrials.gov Identifier: NCT00524290     History of Changes
Other Study ID Numbers: PRO07080043
First Posted: September 3, 2007    Key Record Dates
Last Update Posted: June 14, 2018
Last Verified: June 2018

Keywords provided by Yohei Doi, University of Pittsburgh:
Acinetobacter
infection
isolate

Additional relevant MeSH terms:
Infection
Communicable Diseases
Acinetobacter Infections
Moraxellaceae Infections
Gram-Negative Bacterial Infections
Bacterial Infections